USPTO serial 99036193
MEDERA
Reviewed by CopyMark Law Group
Status 774
- Filing date
- Status date
- Registration date
- —
- Examiner
- FOX III, LYAL L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MEDERA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Boston, MA, KY
Boston, MA, KY
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
ANNA KURIAN SHAW
ANNA KURIAN SHAW HOGAN LOVELLS US LLP555 13TH STREET NWWASHINGTON, DC 20004UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Bacteriological research for others for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Biological research for others for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Biomedical research services for others for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Chemical research for others for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Scientific research in the nature of conducting clinical trials for others; Conducting early evaluations for others in the field of new pharmaceuticals for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Development of biopharmaceutical preparations and medicines for gene and cell therapies for others for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Drug discovery services for others; Engineering services for others, particularly technical project planning and design engineering of lines for the processing of web products; Industrial research for others in the field of regenerative and reparative gene and cell therapies; Medical research laboratory services for others; Pharmaceutical research services for others; Pharmaceutical drug development services for others for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Pharmaceutical product evaluation for others; Providing medical and scientific research information for others in the field of pharmaceuticals and clinical trials; Research and development of new products for others; Research and development of vaccines and medicines for gene and cell therapies for others for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Scientific research for others in the field of gene therapy; Stem cell research services for others; Technical research for others in the field of pharmaceutical studies; Technology research for others in the field of regenerative gene and cell therapies | ACTIVE | — |
| 044 | Blood bank services; Human tissue bank services; Organ and tissue bank services; Stem cell therapy services; Medical services; Consultancy in the field of the medical treatment and diagnosis of cardiovascular diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 23, 2026 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Sep 23, 2026 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Jun 12, 2026 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| May 26, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 26, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 20, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 29, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 29, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 29, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 29, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 29, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 21, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 21, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 21, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 21, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 21, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 21, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 16, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 16, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 16, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 13, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Oct 13, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jul 18, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 18, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 18, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 18, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 9, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 11, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 11, 2025 | NWAP | NEW APPLICATION ENTERED | — |